Efficacy and safety of ursodeoxycholic acid composite on fatigued patients with elevated liver function and/or fatty liver: a multi-centre, randomised, double-blinded, placebo-controlled trial (vol 70, pg 302, 2016)

被引：0
|
作者：
Oh, B.
Choi, W. S.
Park, S. B.
机构：
来源：
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE | 2017年 / 71卷 / 02期
关键词：
D O I：
10.1111/ijcp.12930
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：1
相关论文
共 47 条
  • [1] Efficacy and safety of ursodeoxycholic acid composite on fatigued patients with elevated liver function and/or fatty liver: a multi-centre, randomised, double-blinded, placebo-controlled trial
    Oh, B.
    Choi, W. S.
    Park, S. B.
    Cho, B.
    Yang, Y. J.
    Lee, E. S.
    Lee, J. H.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2016, 70 (04) : 302 - 311
  • [2] The Efficacy of Oligonol in Nonalcoholic Fatty Liver Disease: A Randomized Double-Blinded Placebo-Controlled Trial
    Chayanupatkul, Maneerat
    Sawatdee, Waleerat
    Chutaputti, Anuchit
    Tangkijvanich, Pisit
    JOURNAL OF INTEGRATIVE AND COMPLEMENTARY MEDICINE, 2022, 28 (11): : 904 - 908
  • [3] A randomised, double-blind, placebo-controlled, multi-centre trial to evaluate the safety and efficacy of eculizumab in patients with relapsing neuromyelitis optica: the PREVENT study
    Wingerchuk, D. M.
    Palace, J.
    Cavus, I.
    O'Brien, F.
    Pittock, S. J.
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 759 - 759
  • [4] Effect of an Herbal Product on the Serum Level of Liver Enzymes in Patients with Non-Alcoholic Fatty Liver Disease: A Randomized, Double-Blinded, Placebo-Controlled Trial
    Hormati, Ahmad
    Tooiserkany, Fatemeh
    Mohammadbeigi, Abolfazl
    Aliasl, Fatemeh
    Dehnavi, Hossein Moradi
    IRANIAN RED CRESCENT MEDICAL JOURNAL, 2019, 21 (07)
  • [5] Safety, immunogenicity and efficacy assessment of HIV immunotherapy in a multi-centre, double-blind, randomised, Placebo-controlled Phase Ib human trial
    Boffito, Marta
    Fox, Julie
    Bowman, Christine
    Fisher, Martin
    Orkin, Chloe
    Wilkins, Edmund
    Jackson, Akil
    Pleguezuelos, Olga
    Robinson, Stuart
    Stoloff, Gregory A.
    Caparros-Wanderley, Wilson
    VACCINE, 2013, 31 (48) : 5680 - 5686
  • [6] Efficacy and safety of Kegan Liyan oral liquid for patients with acute pharyngitis: A randomized, double-blinded, placebo-controlled, multi-center trial
    Lin, Luoqi
    Xiao, Jingmin
    Wu, Lei
    Fan, Feiting
    Feng, Wenjie
    Wei, Jun
    Wang, Guangen
    Liu, Gang
    Zhang, Wei
    Lu, Yun
    Li, Yunhui
    Lu, Lijun
    Li, Huimin
    Sun, Shengde
    Gou, Jian
    Dang, Yuqi
    Sun, Xuwu
    Jiang, Baihua
    Qin, Jiangbo
    Zhen, Hui
    Fang, Yun
    Ding, Junping
    Huang, Minling
    Zhao, Wenhan
    Cai, Yan
    Huang, Kaifeng
    Tong, Xiaoping
    Chen, Yuanbin
    Zhang, Hongchun
    Lin, Lin
    PHYTOMEDICINE, 2024, 134
  • [7] The effects of zinc supplementation on the metabolic factors in patients with non-alcoholic fatty liver disease: a randomized, double-blinded, placebo-controlled clinical trial
    Seyed Mohammad Amin Rezaei
    Farzaneh Mohammadi
    Mohammad Hassan Eftekhari
    Fardad Ejtehadi
    Haleh Ghaem
    Nazanin Mohammadipoor
    BMC Nutrition, 9
  • [8] The effects of zinc supplementation on the metabolic factors in patients with non-alcoholic fatty liver disease: a randomized, double-blinded, placebo-controlled clinical trial
    Rezaei, Seyed Mohammad Amin
    Mohammadi, Farzaneh
    Eftekhari, Mohammad Hassan
    Ejtehadi, Fardad
    Ghaem, Haleh
    Mohammadipoor, Nazanin
    BMC NUTRITION, 2023, 9 (01)
  • [9] Safety and efficacy of adjunctive cenobamate (YKP3089) in patients with uncontrolled focal seizures: a multi-centre, double-blind, randomised, placebo-controlled, dose-response trial (vol 19, pg 38, 2020)
    Krauss, G. L.
    Klein, P.
    Brandt, C.
    LANCET NEUROLOGY, 2020, 19 (03): : E3 - E3
  • [10] The effect of chitosan supplementation on liver function, hepatic steatosis predictors, and metabolic indicators in adults with non-alcoholic fatty liver disease: a randomized, double-blinded, placebo-controlled, clinical trial
    Mohsenpoor, Mohammad Ali
    Parastouei, Karim
    Taghdir, Maryam
    Akbarzadeh, Marzieh
    Abbaszadeh, Sepideh
    Heris, Mohammad Ali Abyazi
    Rad, Mohammad Reza Mansouri
    Jafari, Mohammad Amin
    Borzooei, Ronak
    JOURNAL OF HEALTH POPULATION AND NUTRITION, 2025, 44 (01)
12345